North Star Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

North Star Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-935	Closed	-$121K	–	1063
2019 Q4	$121K	Hold	935	–	–	0.01%	415
2019 Q3	$70K	Buy	+935	New	+$110K	0.01%	484
2019 Q2	–	Sell	-935	Closed	-$111K	–	855
2019 Q1	$111K	Hold	935	–	–	0.01%	425
2018 Q4	$102K	Hold	935	–	–	0.01%	405
2018 Q3	$151K	Hold	935	–	–	0.02%	382
2018 Q2	$124K	Hold	935	–	–	0.01%	416
2018 Q1	$69K	Buy	935 +200	+27%	+$13.3K	0.01%	499
2017 Q4	$41K	Hold	735	–	–	0.01%	579
2017 Q3	$33K	Hold	735	–	–	﹤0.01%	620
2017 Q2	$25K	Hold	735	–	–	﹤0.01%	673
2017 Q1	$22K	Hold	735	–	–	﹤0.01%	675
2016 Q4	$20K	Hold	735	–	–	﹤0.01%	644
2016 Q3	$45K	Hold	735	–	–	0.01%	430
2016 Q2	$14K	Hold	735	–	–	﹤0.01%	585
2016 Q1	$14K	Hold	735	–	–	﹤0.01%	554
2015 Q4	$28K	Hold	735	–	–	0.01%	456
2015 Q3	$24K	Hold	735	–	–	﹤0.01%	494
2015 Q2	$22K	Hold	735	–	–	﹤0.01%	484
2015 Q1	$10K	Hold	735	–	–	﹤0.01%	616
2014 Q4	$11K	Hold	735	–	–	﹤0.01%	573
2014 Q3	$16K	Hold	735	–	–	﹤0.01%	491
2014 Q2	$22K	Hold	735	–	–	﹤0.01%	478
2014 Q1	$18K	Buy	+735	New	+$18.7K	﹤0.01%	485

Other funds holding SRPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

North Star Investment Management's SRPT Position: Q1 2020 in Review

North Star Investment Management sold out of Sarepta Therapeutics (SRPT) in Q1 2020, closing a stake of 935 shares — an estimated $121K sold.

North Star Investment Management first reported a position in SRPT in Q1 2014 and held it in 23 quarters. The position peaked at $151K in Q3 2018. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2020.

North Star Investment Management reported no remaining Sarepta Therapeutics position as of Q1 2020 after selling out during the quarter.
North Star Investment Management sold 935 Sarepta Therapeutics shares in Q1 2020, an estimated $121K.
North Star Investment Management first reported a position in Sarepta Therapeutics in Q1 2014 and held it in 23 quarters.
North Star Investment Management's Sarepta Therapeutics position peaked at $151K in Q3 2018.
366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2020.

Based on North Star Investment Management's 13F filing for Q1 2020, filed 23 Apr 2020.